SRZN Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: Surrozen, Inc.

Surrozen to Present at Upcoming Healthcare Investor Conferences

25 days ago - By: Surrozen, Inc.

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Surrozen, Inc.

Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Surrozen, Inc.

Surrozen to Present at Upcoming Healthcare Investor Conference

3 months ago - By: Surrozen, Inc.

Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Surrozen, Inc.

Surrozen to Present at Upcoming Healthcare Investor Conference

a year ago - By: Surrozen, Inc.

Surrozen to Present at Upcoming Healthcare Investor Conferences

a year ago - By: BusinessInsider

SRZN Stock Earnings: Surrozen Misses EPS for Q2 2024

a year ago - By: InvestorPlace

SRZN Stock Earnings: Surrozen Misses EPS for Q2 2024

2 years ago - By: BusinessInsider

SRZN Stock Earnings: Surrozen Beats EPS for Q1 2024

3 months ago - By: Surrozen, Inc.

Surrozen to Present at Upcoming Healthcare Investor Conference

4 months ago - By: The Motley Fool

Surrozen Reports Q2 Profit on Gains

4 months ago - By: Surrozen, Inc.

Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Surrozen, Inc.

Surrozen to Present at Upcoming Healthcare Investor Conference

7 months ago - By: Zacks Investment Research

Down -29.72% in 4 Weeks, Here's Why Surrozen (SRZN) Looks Ripe for a Turnaround

7 months ago - By: Surrozen, Inc.

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

2 years ago - By: InvestorPlace

SRZN Stock Earnings: Surrozen Beats EPS for Q1 2024

2 years ago - By: BusinessInsider

SRZN Stock Earnings: Surrozen Misses EPS for Q1 2023

2 years ago - By: InvestorPlace

SRZN Stock Earnings: Surrozen Misses EPS for Q1 2023

7 months ago - By: Surrozen, Inc.

Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update

8 months ago - By: Surrozen, Inc.

Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates

9 months ago - By: Surrozen, Inc.

Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases

10 months ago - By: Benzinga - Mentions: WOR FHTX KSCP PHIN

This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

a year ago - By: Benzinga - Mentions: CYCC AHG ONCO EYEN ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

a year ago - By: Yahoo Finance - Mentions: RJF CHWY SQ JBHT

Block upgraded, Bumble downgraded: Wall Street's top analyst calls

a year ago - By: Surrozen, Inc.

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

a year ago - By: Surrozen, Inc.

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

a year ago - By: Surrozen, Inc.

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

a year ago - By: Surrozen, Inc.

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

1 years ago - By: Surrozen, Inc.